Concepedia

Gwanghee Lee

GL

Statistics

Publications

1

Citations

72

H-Index

1

Active since

2023

Affiliations

BioBridges (United States)(Current)

Gwanghee Lee is an author at BioBridges (United States) specializing in mutation, targeted therapy, and targeted cancer therapy.

ORCID

Publications per year

2023–2023

1

Publications

1

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer

Sun Min Lim, Toshio Fujino, Chulwon Kim et al. · Clinical Cancer Research · 2023 · 72 citations · Full text

, , +15

1–1 of 1